ストックスクリーナーアプリを入手
6.29
6.61%
0.39
前日終値:
$5.90
開ける：
$5.89
24時間の取引高:
5,654
Relative Volume:
0.24
時価総額：
$33.24M
収益：
-
当期純損益:
$-59.63M
株価収益率:
-0.624
EPS:
-10.08
ネットキャッシュフロー:
$-49.92M
1週間 パフォーマンス:
-15.68%
1か月 パフォーマンス:
-38.81%
6か月 パフォーマンス:
-56.26%
1年 パフォーマンス:
-9.50%
1日の値動き範囲:
$5.89
$6.31
1週間の範囲:
$5.89
$7.5562
52週間の値動き範囲:
$5.00
$19.00
Vicarious Surgical Inc Stock (RBOT) Company Profile
RBOT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RBOT
Vicarious Surgical Inc
|
6.2969 | 39.70M | 0 | -59.63M | -49.92M | -10.08 |
|
ABT
Abbott Laboratories
|
132.12 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.54 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
388.02 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.32 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.85 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Vicarious Surgical Inc Stock (RBOT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-03-04 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | 開始されました | Credit Suisse | Outperform |
| 2021-12-07 | 開始されました | Cowen | Outperform |
| 2021-11-05 | 開始されました | Canaccord Genuity | Buy |
| 2021-10-18 | 開始されました | BTIG Research | Buy |
| 2021-10-07 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Vicarious Surgical Inc (RBOT) 最新ニュース
Breakout Traders Target Vicarious Surgical Inc. on Recovery SetupWeekly Trend Recap & Trade Opportunity Analysis - thegnnews.com
Vicarious Surgical Inc. Uptrend in Early Stages Indicators Say YesEarnings Recap Report & Weekly Market Pulse Updates - classian.co.kr
Will Vicarious Surgical Inc. Equity Warrant Bounce From 52 Week Low2025 Bull vs Bear & Weekly High Conviction Ideas - 선데이타임즈
RSI Reset May Fuel Rebound in Vicarious Surgical Inc.July 2025 Review & Long-Term Safe Investment Ideas - 선데이타임즈
Vicarious Surgical’s Earnings Call: Progress Amid Challenges - MSN
Will Vicarious Surgical Inc. benefit from rising consumer demandWeekly Market Outlook & Long-Term Growth Stock Strategies - thegnnews.com
Vicarious Surgical outlines new CEO transition and strategic shift to production system readiness amid $50M cash burn target - MSN
Moving Average Crossover Confirms Uptrend in Vicarious Surgical Inc.2025 Price Action Summary & Daily Profit Focused Stock Screening - 선데이타임즈
Vicarious Surgical Reports Improved Q2 Financials and Leadership Change - TipRanks
Vicarious Surgical appoints new CEO; co-founder Adam Sachs to remain as president - MSN
Published on: 2025-08-15 06:11:29 - thegnnews.com
Using data tools to time your Vicarious Surgical Inc. exit2025 Macro Impact & Short-Term High Return Strategies - Newser
Vicarious Surgical delays robot clinical timeline - Yahoo Finance
How hedge fund analytics apply to Vicarious Surgical Inc. Equity Warrant stockQuarterly Trade Report & Precise Buy Zone Tips - Newser
Best data tools to analyze Vicarious Surgical Inc. Equity Warrant stockJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - Newser
Vicarious Surgical Inc. stock volume spike explainedTrade Risk Summary & Community Trade Idea Sharing - Newser
Regression analysis insights on Vicarious Surgical Inc. performanceWeekly Investment Recap & Weekly Watchlist of Top Performers - Newser
What does recent volatility data suggest for Vicarious Surgical Inc.Analyst Upgrade & Smart Investment Allocation Insights - Newser
Using economic indicators to assess Vicarious Surgical Inc. potentialPortfolio Value Summary & Low Drawdown Investment Ideas - Newser
Trend analysis for Vicarious Surgical Inc. this weekBuy Signal & Growth Oriented Trade Recommendations - Newser
What MACD and RSI say about Vicarious Surgical Inc.July 2025 Summary & Expert Approved Trade Ideas - Newser
Vicarious Surgical delays robot timeline - medtechdive.com
RBOT Plunges 24.6%: Leadership Shift and Sector Turbulence Spark Investor Frenzy - AInvest
What institutional flow reveals about Vicarious Surgical Inc.2025 Stock Rankings & Real-Time Volume Triggers - Newser
Piper Sandler lowers Vicarious Surgical stock price target on delayed clinical use By Investing.com - Investing.com South Africa
Piper Sandler lowers Vicarious Surgical stock price target on delayed clinical use - Investing.com Nigeria
Tools to monitor Vicarious Surgical Inc. Equity Warrant recovery probabilityMarket Sentiment Summary & Proven Capital Preservation Methods - Newser
Will Vicarious Surgical Inc. rebound enough to break evenJuly 2025 Movers & Daily Oversold Bounce Ideas - Newser
Vicarious Surgical Inc. (NYSE:RBOT) Q2 2025 Earnings Call Transcript - Insider Monkey
Earnings visualization tools for Vicarious Surgical Inc.2025 AllTime Highs & Reliable Intraday Trade Alerts - Newser
Live market analysis of Vicarious Surgical Inc.July 2025 Macro Moves & Low Risk Entry Point Guides - Newser
Tick level data insight on Vicarious Surgical Inc. volatilityMarket Sentiment Report & Low Risk Profit Maximizing Plans - Newser
Combining price and volume data for Vicarious Surgical Inc. Equity Warrant2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser
Is Vicarious Surgical Inc. Equity Warrant forming a bottoming baseRecession Risk & Fast Exit/Entry Strategy Plans - Newser
Vicarious Surgical Narrows Loss in Q2 - AOL.com
Can Vicarious Surgical Inc. Equity Warrant recover in the next quarterProfit Target & Fast Gaining Stock Strategy Reports - Newser
Vicarious Surgical Inc (RBOT) Q2 2025 Earnings Call Highlights: Strategic Delays and Cost Reductions By GuruFocus - Investing.com Canada
Published on: 2025-08-13 09:06:39 - beatles.ru
Published on: 2025-08-13 01:02:27 - Newser
Will Vicarious Surgical Inc. Equity Warrant outperform the marketEarnings Growth Report & Real-Time Volume Analysis - Newser
Will a bounce in Vicarious Surgical Inc. Equity Warrant offer an exitNew Guidance & Expert Approved Momentum Trade Ideas - Newser
Vicarious Surgical's Q2 2025: Unraveling Contradictions in Clinical Trials, System Readiness, and Supply Chain Stability - AInvest
Vicarious Surgical Narrows Loss in Q2 - The Motley Fool
Statistical indicators supporting Vicarious Surgical Inc.’s strength [Earnings Summary Report]Low Drawdown Investment Ideas - Newser
Price momentum metrics for Vicarious Surgical Inc. Equity Warrant explained [Market Risk Analysis] - Newser
Earnings call transcript: Vicarious Surgical’s Q2 2025 results show cost efficiency - Investing.com Nigeria
Transcript : Vicarious Surgical Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
Surgical Robotics Pioneer Vicarious Cuts Losses 13% as New CEO Takes Helm - Stock Titan
Vicarious Surgical Reports Second Quarter 2025 Financial Results - Bluefield Daily Telegraph
Vicarious Surgical Inc (RBOT) 財務データ
収益
当期純利益
現金流量
EPS
0.03%
0.56%
大文字化:
|
ボリューム (24 時間):